C- Arms Market Size, Share, Growth, Trends, and Global Industry Analysis: Size, Share, Growth, Trends, and Industry Analysis By Machine Type (Fixed, Mobile, Full size, Mini, Super C, and Compact), By Tube Type (Rotating Anode Tube and Stationary Anode Tube), Imaging Technology (Image Intensifiers, C-arm computed tomography, and Flat-panel detectors (FDP)), By Application (Cardiology, Gastroenterology, Neurology, Orthopedics, Trauma & Emergency, Pain Management, Oncology, and Other), By End User (Hospitals, Diagnostic Centers, Clinics, Others) and Region Forecast 2020-2031

C-Arms Market size was valued at US$ 2,089.4 million in 2024 and is expected to reach US$ 2,901.0 million by 2031, growing at a significant CAGR of 4.8% from 2025-2031. A c-arm is a fluoroscopic intraoperative imaging device used mostly in orthopedic, surgical, and emergency care operations. It is an image scanner intensifier with radiographic capabilities. These tools deliver high-resolution X-ray images in real-time, enabling medical professionals to track progress and make corrections right away. The transition from conventional X-ray image intensifier technology to digital flat-panel detectors (FPDs) has provided significant benefits for diagnostic imaging. For instance, surgeons and interventionalists employ OEC Elite CFD mobile c-arms from GE Hospital in several healthcare settings. Using innovative software capabilities like Live Zoom, the CMOS flat detector helps them understand more anatomy and offers outstanding image quality at a lesser dosage. By enhancing the clinical workflow, the improved location and usability are also promoting more efficiency. Besides the traditional C-arms, the recent trend in the C-arms industry is incorporating artificial intelligence at the software level. Artificial intelligence (AI) has advanced quickly in medicine, particularly radiology.

AI improves workflow, helps with quantitative radiology, aids in the discovery of genomic markers, and, if used, enhances image acquisition with C-arms. AI speeds up imaging time, improves resolution, and allows for dose reduction by improving smaller bits of data to the same extent as bigger data sets. Thus, considerations like early illness detection help to design a patient's therapy for long-term requirements. AI technology may review medical imaging options and identify the best treatment for bodily severe problems. The introduction and rising acceptance of minimally invasive procedures are the primary drivers for expanding the C-arms market's size in the forecast period. Since surgeons have a restricted view of the interior body systems, treatments often include making small wounds on the operating table.

These technologies collect real-time photos that give surgeons visual cues. It also increases surgical safety and reduces human error. This enhancement of safety boosts the confidence of patients and surgeons, which is attracting more surgeons and hospitals to adopt C-arms live imaging systems during surgical procedures. This increase in preference can be estimated to propel the C-arms market size in the foretell period. These instruments are now used in spine surgery, and cardiac, urological, vascular, and neurovascular applications. Pain is typically treated via a minimally invasive method, which involves injecting a nerve blocker, implanting a medication delivery device, or activating a component of the nervous system.

In such procedures, mobile systems provide for navigation to the proper spot. With the increase in specialized surgeries mentioned above due to the high prevalence of neurological, genetic, immunological, gastroenterological, etc. diseases and the adaptation of advanced technology in surgeries, it can be anticipated that the demand and the market for C-arms devices will flourish in the forecast period. Despite the preference by surgeons and has several advantages, the high cost of the devices, the collateral cost of running the device like high electricity consumption, specialized printer for printing the device, and maintenance costs are impeding the C-arms market growth.

Key Developments:

• In January 2022, to increase workflow effectiveness and improve the results of endovascular treatments, Philips announced the integration of cloud-based AI and 3D mapping into their transportable C-arm System Series, Zenition. Philips added that by combining these technologies, radiation exposure would be reduced by 50%, and process times would be slashed by more than 20%.
• In January 2019, The Alphenix 4D CT was purchased by the West Virginia University (WVU) Heart and Vascular Institute from Canon Medical Systems USA Inc. To enhance capabilities for interventional treatments and increase patient care in the neighborhood, the system offers an angiography configuration.